Norges Bank Embecta Corp. Transaction History

Norges Bank

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$10.13 - $14.6 $1.88 Million - $2.71 Million	185,801 New	185,801 $2.32 Million
Q4 2023 Feb 09, 2024	BUY	$12.87 - $19.09 $5.2 Million - $7.72 Million	404,292 New	404,292 $7.65 Million
Q3 2023 Nov 13, 2024	BUY	$15.0 - $22.17 $6.48 Million - $9.58 Million	432,225 New	432,225 $6.5 Million
Q3 2023 Nov 13, 2023	SELL	$15.0 - $22.17 $7.22 Million - $10.7 Million	-481,159 Closed	0 $0
Q2 2023 Aug 14, 2024	SELL	$21.6 - $30.69 $1.39 Million - $1.97 Million	-64,300 Reduced 34.61%	121,501 $2.62 Million
Q2 2023 Aug 14, 2023	SELL	$21.6 - $30.69 $17 Million - $24.2 Million	-787,376 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$23.07 - $32.77 $2.22 Million - $3.16 Million	96,301 New	96,301 $2.71 Million
Q4 2022 Feb 14, 2023	BUY	$25.29 - $35.48 $10.1 Million - $14.2 Million	400,407 New	400,407 $10.1 Million
Q3 2022 Nov 13, 2023	BUY	$24.0 - $33.42 $11.5 Million - $16.1 Million	481,159 New	481,159 $14.1 Million
Q2 2022 Aug 14, 2023	BUY	$24.78 - $33.36 $19.5 Million - $26.3 Million	787,376 New	787,376 $19.9 Million

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.